Clik here to view.
FitPet Plans to Establish ‘Global Integrated Pet Lifestyle Platform’ Based on...
SEOUL, South Korea “We are creating a one-stop ecosystem for effective healthcare for pets.” The age has come when pets can be checked and managed with a simple diagnostic kit without having to go...
View ArticleClik here to view.
Lydia AI Raises $8 Million in Series A+ Funding Round to Insure the Next...
TORONTO Lydia AI, formerly known as Knowtions Research, has announced the closing of $8 million USD in a Series A+ funding round. Led by existing investor, Information Venture Partners, and with...
View ArticleClik here to view.
Treadwell Therapeutics宣布收购专注于新型TCR-T细胞疗法的TIO Bioventures投资组合公司TCRyption Inc.
纽约和香港 (美国商业资讯)–Treadwell Therapeutics今天宣布收购TCRyption Inc.，后者专注于新型TCR-T细胞疗法，是TIO...
View ArticleClik here to view.
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib)...
CAMBRIDGE, Mass. & BEIJING & MOSCOW BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve...
View ArticleClik here to view.
印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛；印度Rajalakshmi工程学院获得亚军
东京 (美国商业资讯)–来自印尼生命科学与技术学院(School of Life Sciences and Technology, Indonesia)的Alfred Patisenah和Daisy Ramadhani在著名的Fujio Cup Quiz (FCQ)比赛中获胜。FCQ是2021年日印再生医学中心NICHE大会(NCRM NICHE...
View ArticleClik here to view.
HighTide Therapeutics to Present New PSC and NASH Clinical Data at AASLD 2021
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company, announced today the publication of multiple abstracts highlighting positive Phase 2...
View ArticleClik here to view.
FINVASIA Acquires Gini Health, Expands Into Healthcare Services
CHANDIGARH, India FINVASIA, today, announced its investment in Gini Health, a Canada based healthcare technology company that pioneered DNA and lifestyle data based personalized health to prevent...
View ArticleClik here to view.
Reata Pharmaceuticals Submits Marketing Authorization Application to the...
PLANO, Texas & ZUG, Switzerland Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced its...
View ArticleClik here to view.
In a Clinical Trial, Daytime Exposure to Short-Wavelength Enriched Light With...
ANSAN, South Korea Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced that following Seoul National University in Korea and Basel...
View ArticleClik here to view.
武田将收购GammaDelta Therapeutics，以加速开发针对实体瘤的异体γδT细胞疗法
日本大阪和伦敦 (美国商业资讯)–武田药品工业株式会社（Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK，简称“武田”）今天宣布行使其收购GammaDelta Therapeutics Limited (“GammaDelta”)的选择权。GammaDelta...
View ArticleClik here to view.
SanBio Announces Publication Comparing Outcome Measures for Persons With...
TOKYO & MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. of Tokyo, Japan , SanBio, Inc. of Mountain View, California, US, and SanBio Asia Pte. Ltd. of Singapore) (TOKYO:4592), hereby...
View ArticleClik here to view.
GC Pharma Reports Q3 2021 Results
YONGIN, South Korea GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the...
View ArticleClik here to view.
Frazier Healthcare Partners完成8.3亿美元的生命科学公共基金超额认购
加州门罗帕克 (美国商业资讯)–Frazier Healthcare Partners今天宣布，Frazier生命科学公共基金有限合伙企业(Frazier Life Sciences Public Fund, L.P.)已完成交割，该基金在超额认购筹款中募得近8.3亿美元的资本认缴金额，超过其原定目标。 Frazier生命科学公共基金由执行合伙人Albert...
View ArticleClik here to view.
Clik here to view.
Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase...
BOSTON Compass Therapeutics, Inc. (OTC:CMPX) today provided an update on the clinical development of CTX-009 (also known as ABL001), a dual anti-angiogenic bispecific antibody targeting DLL4 and...
View ArticleClik here to view.
Nuritas™募集4500万美元，将扩大其肽发现平台规模并向全球扩张
都柏林 –(美国商业资讯)–以全新方式发现和开发植物源生物活性肽的生物技术公司Nuritas已完成4,500万美元的B轮融资。此次投资由总部位于芝加哥的Cleveland Avenue, LLC领投，其他投资方包括Grosvenor旗下的Wheatsheaf Group、欧洲循环生物经济基金(ECBF)、总部位于新加坡的Vertex Holdings、Nutresa...
View ArticleClik here to view.
ViroStopスプレーがCovid-19に対する予防効果を持つことを示す臨床試験
チューリッヒ （ビジネスワイヤ） — 最近実施された臨床試験で、ViroStop鼻咽頭スプレーは、Covid-19の感染を予防する効果を持ち、同時にウイルスに対する体内の抗体反応を高めることが示されました。これらの結果は、ラボ試験での結果と、先行試験（本製品がウイルスの排出を低減することで、疾患の蔓延を遅らせることを示した）の結果を裏付けるものです。...
View ArticleClik here to view.
Bluehole Publishes a Feature Story on Global Advocacy for Tobacco Harm...
SHENZHEN, China China’s leading vaping media, Bluehole New Consumption, today published a feature story on global advocacy for tobacco harm reduction prior to WHO FCTC COP9, while atomization offers...
View ArticleClik here to view.
セラメックスが更年期障害を治療するための非ホルモン系選択肢となるフェマレルでOTC市場に参入
ロンドン — （ビジネスワイヤ） — 女性の健康のために献身する企業であるセラメックスはこのほど、更年期障害の症状を治療するためのフェマレル（Femarelle®）の製品ライセンスを取得しました。フェマレルは2022年の第2四半期から各国市場で提供します。今回の商業化契約は、本製品を開発した企業であるセキュア・ファーマシューティカルズ・リミテッドと締結したものです。...
View ArticleClik here to view.
Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场
伦敦 –(美国商业资讯)–女性健康公司Theramex已于近期获得绝经治疗药物Femarelle®的许可，将自2022年第二季度起在各国销售该产品。Femarelle由Se-cure Pharmaceuticals Ltd.开发，Theramex已与该公司达成相关商业化协议。...
View Article